United Kingdom: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

European Commission Proposes Simplifying The Rules On EU Medical And In-Vitro Diagnostic Devices

The proposed simplification is intended to reduce the administrative burden on EU manufacturers of medical and in-vitro diagnostic devices and lower their compliance-related costs...

United Kingdom Healthcare

CM

Crowell & Moring LLP

M&C In The News: What's Holding Back UK Life Sciences?

As the UK sets its sights on becoming the world's third-largest life sciences economy by 2035, questions around how to turn ambition into reality are growing louder.

United Kingdom IP

MC

Marks & Clerk

Precision Breeding In England: Navigating The New Regulatory Framework

On 13 November 2025, England introduced the Genetic Technology (Precision Breeding) Regulations 2025, creating a new regulatory framework for precision bred plants.

United Kingdom Healthcare

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Updates Announced To The UK-US Trade Deal See Greater Support For The Pharmaceuticals Sector

The tariffs announced earlier this year by President Donald Trump on imports from all of the United States' (US) trading partners marked a significant change in trade dynamics. Having introduced a 10% baseline tariff...

United Kingdom International

GW

Gowling WLG

SPC Waiver: No MA? UK Says Ok

United Kingdom IP

PC

Potter Clarkson

Current Life Sciences Insurance Trends And The Imperative For Specialised Coverage

United Kingdom Healthcare

BJ

Browne Jacobson

Confidentiality In Clinical Trials: Arbitration As The Preferred Route For Dispute Resolution

United Kingdom Litigation

BJ

Browne Jacobson

Climate Resilient Crops – Mitigating The Risks Of Climate Change

United Kingdom Environment

JA

J A Kemp LLP

Cross-border Collaboration In Life Sciences: How To Make It Work

Worldwide Healthcare

BJ

Browne Jacobson

Unlocking Value Creation In Healthcare: How AI Can Reverse Private Equity's Return Challenges - Part 1: HealthTech And Tech-enabled Services

United Kingdom Healthcare

A

AlixPartners

Hot Topics: Life Sciences - October 2025

United Kingdom Healthcare

AG

Addleshaw Goddard

How MHRA's International Reliance Is Shaping UK Medicine Regulation

United Kingdom Healthcare

BJ

Browne Jacobson

Technology-Enabled Care In The UK: Legal And Technical Developments To Watch

United Kingdom Healthcare

BJ

Browne Jacobson

The Dog That Barks: The UK's CMA Is Proposing Major Reforms To Veterinary Businesses

United Kingdom Healthcare

AP

Arnold & Porter

CSRD And CSDDD Version 2.0 – The EU's Sustainability Framework Redefined

United Kingdom Commercial

TS

Travers Smith LLP

Fresh Evidence On Witness Credibility Resulted In Tribunal Decision Being Set Aside

United Kingdom Employment

WS

Wrigleys Solicitors

When Can Social Care Legally Remove Your Children? (4 December 2025) (Video)

United Kingdom Family

DL

Duncan Lewis & Co Solicitors

The EU's Digital Omnibus: Everything You Need To Know

European Union Technology

IL

Ius Laboris

Data Centres: Common Issues And How To Avoid Them (Video)

United Kingdom Real Estate

FE

Fenwick Elliott LLP

Arbitrating Innovation: Resolving IP Disputes In The Life Sciences Sector

As biotech and AI converge, arbitration is emerging as the preferred forum for complex intellectual property disputes - particularly when the underlying science defies straightforward explanation.

United Kingdom Healthcare

BJ

Browne Jacobson

The Importance Of AI In The Development Life Sciences

The life sciences industry (which for the purposes of this article are seen as encompassing medicine, biotechnology and pharmaceuticals)...

United Kingdom Healthcare

BJ

Browne Jacobson

MHRA And NICE Launch Aligned Approvals Pathway

On 10 October 2025, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence...

United Kingdom Healthcare

AP

Arnold & Porter

Biopharma M&A Activity – Strategics Continue To Lead The Way

As we entered 2025, we were hopeful for a more upbeat year for pharma M&A activity but, with headwinds still swirling, a dramatic change of pace seemed unlikely.

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Venture Investment In Life Sciences – Activity Update & Outlook (US & Europe)

Worldwide Healthcare

KL

Herbert Smith Freehills Kramer LLP

EU Data Act: Is Your Business Ready?

European Union Privacy

AG

Addleshaw Goddard

AI In Medical Devices: Patent Eligibility

United Kingdom IP

MC

Marks & Clerk

Article 22 Trends In Pharma M&A: Call-In Powers And Timing

United Kingdom Healthcare

AP

Arnold & Porter

Interview With Citrine Informatics: AI, Data, And The Future Of Materials Science

United Kingdom Technology

KL

Keltie LLP

A Milestone For Precision Breeding But Will The UK-EU Reset Pause Progress?

European Union Healthcare

M

Murgitroyd

Biopharma M&A Activity – As We Enter The Latter Months Of 2025, Strategics Continue To Lead The Way

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Supporting Growth - What Does The UK's Industrial Strategy Mean For Infrastructure?

United Kingdom Energy

GW

Gowling WLG

Life After Separation: What The Future Holds For Pharma Companies And Their Divested Consumer Healthcare Divisions

United Kingdom Healthcare

AO

A&O Shearman

Immigration And The UK's Industrial Vision

United Kingdom Immigration

LS

Lewis Silkin

Biopharma M&A Activity – As We Enter The Latter Months Of 2025, Strategics Continue To Lead The Way

As we entered 2025, we were hopeful for a more upbeat year for pharma M&A activity but, with headwinds still swirling, a dramatic change of pace seemed unlikely.

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Supporting Growth - What Does The UK's Industrial Strategy Mean For Infrastructure?

The return of the UK Industrial Strategy (UKIS) the last edition of which was published by Theresa May's Government in 2017, represents a "statement of intent" by the UK Government of the areas where it will seek...

United Kingdom Energy

GW

Gowling WLG

Life After Separation: What The Future Holds For Pharma Companies And Their Divested Consumer Healthcare Divisions

In recent years, many of the world's biggest pharmaceutical companies have carved out and spun off their consumer health divisions in an effort to refocus on core strategic areas and free up cash for investment

United Kingdom Healthcare

AO

A&O Shearman

Immigration And The UK's Industrial Vision

In today's global economy, competition to attract the most desirable talent is fierce with many countries seeking to improve their attractiveness.

United Kingdom Immigration

LS

Lewis Silkin

AI In The Healthcare Sphere: Public And Private Considerations

United Kingdom Technology

BJ

Browne Jacobson

Tackling Tech Debt, Unlocking Value In Healthcare Portfolio Companies

Technology is no longer a back-office function—it's a strategic lever for accelerating EBITDA, scaling platforms, and achieving rapid value creation. Yet many healthcare private equity portfolio companies...

United Kingdom Healthcare

A

AlixPartners

Court Of Appeal Deals With Price-less Contract

Recently, in the case of KSY Juice Blends UK Ltd v Citrosuco GmbH [2025] EWCA Civ 760, the Court of Appeal considered contractual certainty and implied pricing terms for water-extracted soluble orange solids ("wesos").

United Kingdom Litigation

LS

Lewis Silkin

Leading The Way In Life Sciences IP: Q&A With Laura Kehoe

Keltie is rated as ‘Outstanding' in the 2025 WIPR UK Patents Rankings. This ranking recognises the top firms in UK patent law for their expertise, reputation and client service.

United Kingdom IP

KL

Keltie LLP

Early Access Service To Launch For Innovative Medical Devices

A key platform of the government's Life Sciences Sector Plan and the 10-Year Health Plan is for the UK to be a global leader in life sciences.

United Kingdom Healthcare

BJ

Browne Jacobson

UK Court Of Appeal Upholds Moderna MRNA Patent Against Pfizer/BioNTech

United Kingdom IP

GP

Goodwin Procter LLP

Launch Of The Biotech And Biomanufacturing Hub

United Kingdom IP

B

Boult Wade Tennant

Covert Medication – What You Need To Know (8 August 2025)

United Kingdom Healthcare

DL

Duncan Lewis & Co Solicitors

UK Medical Devices Regulations: Further Changes Afoot

United Kingdom Healthcare

AP

Arnold & Porter

UK Proposes Early Access Service For Innovative Medical Devices

United Kingdom Healthcare

AP

Arnold & Porter

EU Regulatory Reform For Medicinal Products: Bolar Exemption

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Watch What The Federal Government Does, Not What It Says, About Artificial Intelligence

United Kingdom Technology

IG

IR Global

Product Regulation And Metrology Bill Receives Royal Assent

United Kingdom Healthcare

JD

Jones Day

Hot Topics: Life Sciences

United Kingdom Healthcare

AG

Addleshaw Goddard

Virtual And Digital Health Digest – July 2025

United Kingdom Healthcare

AP

Arnold & Porter

Supporting Growth: The UK's Plan To Unlock The Potential Of Life Sciences

United Kingdom Healthcare

GW

Gowling WLG

The UK Government Has Plans: What Does This Mean For The Life Sciences Sector?

United Kingdom Healthcare

AP

Arnold & Porter

Life Science Sector Plans Issued

United Kingdom Healthcare

LS

Lewis Silkin

A New European Strategy To Foster Life Sciences Innovation And Market Access

European Union Healthcare

AO

A&O Shearman

Tackling The Source Of Phantom Limb Pain With Nerve Stimulation

United Kingdom IP

MC

Marks & Clerk

See more

Latest Videos

See more

Protecting UK/EU Patents Post-Covid (Video)

AP

Arnold & Porter

Legally Vocal: Patrick Duxbury On His COVID-19 Vaccine Work And 20-Year Career In Life Sciences (Video)

GW

Gowling WLG

Claim One – #01 EPO Oral Proceedings (Video)

H

HLK

Using Patents To Raise Finance - Dehns And Green Biologics (Video)

D

Dehns

Real World Evidence (Video Content)

D

Deloitte

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More